Net Loss Per Share

3 Months Ended

Mar. 31, 2022

Basic and diluted net loss per share for the periods set forth below is calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2022		2021
Numerator:
Net loss	$	(18,276)	$	(15,749)

Denominator:
Weighted-average number of common shares used in loss per share - basic and diluted	47,441,821		46,981,016
Loss per share - basic and diluted	$	(0.39)	$	(0.34)

The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average shares outstanding, as they would be anti-dilutive. For the three months ended March 31, 2022 and 2021, respectively, all of the Company’s options to purchase common stock, restricted stock units outstanding, and performance options were assumed to be anti-dilutive as earnings attributable to common stockholders was in a loss position.


	Three Months Ended March 31,
	2022	2021
Options to purchase common stock	5,822,796	6,203,490

Restricted stock units	1,765,418	460,907
Performance units	960,000	—
Performance options	1,035,000	1,035,000

The Company has the option to settle the conversion obligation for the Convertible Notes in cash, shares or any combination of the two. As the Convertible Notes are not convertible as of March 31, 2022, they are not participating securities and they will not have an impact on the calculation of basic earnings or loss per share. Based on the Company’s net loss position, there is no impact on the calculation of dilutive loss per share during the three month periods ended March 31, 2022 and 2021, respectively. The Company uses the if-converted method for the Convertible Notes